+Search query
-Structure paper
Title | ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1. |
---|---|
Journal, issue, pages | Cancer Immunol. Immunother., Vol. 72, Page 4145-4159, Year 2023 |
Publish date | May 8, 2023 (structure data deposition date) |
![]() | Enell Smith, K. / Fritzell, S. / Nilsson, A. / Barchan, K. / Rosen, A. / Schultz, L. / Varas, L. / Sall, A. / Rose, N. / Hakansson, M. ...Enell Smith, K. / Fritzell, S. / Nilsson, A. / Barchan, K. / Rosen, A. / Schultz, L. / Varas, L. / Sall, A. / Rose, N. / Hakansson, M. / von Schantz, L. / Ellmark, P. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 3.1 Å |
Structure data | ![]() PDB-8oz3: |
Chemicals | ![]() ChemComp-HOH: |
Source |
|
![]() | IMMUNE SYSTEM / complex / single chain Fv / tumor necrosis factor |